Universitair Medisch Centrum Groningen

Address
Hanzeplein 1

Sponsor Overview

assignment
76
sponsored trials
science
91
molecules
location_city
141
research centres
public
12
countries
person_search
262
investigators

Specializations

Kidney disease and transplantation

Research activity is strongly centered on chronic kidney disease, albuminuria, autosomal dominant polycystic kidney disease, and kidney failure, with additional work in kidney transplantation and lung transplantation.

  • Renal function preservation
  • Proteinuria and albuminuria
  • Polycystic kidney disease
  • Transplant immunology

The portfolio also includes studies in primary aldosteronism and methods related to glomerular filtration rate assessment.

Oncology and haematologic malignancies

The sponsor funds research across multiple cancer types, including diffuse large B-cell lymphoma, non-small cell lung cancer, head and neck squamous cell carcinoma, colorectal cancer, cervical cancer, ovarian cancer, and hepatocellular carcinoma.

  • Lymphoma and multiple myeloma
  • Solid tumours and metastatic disease
  • Head and neck cancer
  • Cell therapy and immunotherapy

Its oncology work also includes molecular imaging, fluorescence-guided surgery, and studies in cancer biomarkers and tumour targeting.

Inflammatory, autoimmune, and gastrointestinal disease

Important therapeutic areas include inflammatory bowel disease, Crohn’s disease, ulcerative colitis, rheumatoid arthritis, psoriasis, giant cell arteritis, polymyalgia rheumatica, and Sjögren’s disease.

  • Immune-mediated inflammation
  • Rheumatologic disease
  • Gastrointestinal inflammation
  • Dermatologic immune disorders

Additional work addresses eosinophilic granulomatosis with polyangiitis, hand eczema, and immune-related tissue imaging.

Neurology, psychiatry, and neurodegeneration

Clinical research spans depression, psychosis, Parkinson’s disease, multiple sclerosis, amyotrophic lateral sclerosis, and Alzheimer’s disease, alongside other neurodegenerative disorders.

  • Treatment-resistant depression
  • First-episode psychosis
  • Movement disorders
  • Cognitive impairment

The portfolio also includes studies in electroconvulsive therapy, esketamine, and biomarker-based brain imaging.

Cardiometabolic, respiratory, and critical care

Further research covers heart failure, cardiovascular disease, type 1 diabetes, type 2 diabetes, chronic obstructive pulmonary disease, ECMO, and acute respiratory distress syndrome.

  • Cardiorenal disease
  • Diabetes-related kidney injury
  • Respiratory failure
  • Extracorporeal life support

Additional interests include post-acute sequelae of COVID-19, long COVID, ATTR cardiomyopathy, and metabolic inflammation.

Sponsored Trials

Trial Name Country Status
A Multicenter Randomized Placebo-Controlled Study of Leflunomide for Relapse Prevention in Polymyalgia Rheumatica During Corticosteroid TaperingThe Netherlands The NetherlandsRecruiting
ASPIRE-1: Individual and combined endothelin receptor and SGLT2 antagonism in adults with type 1 diabetes mellitus and chronic kidney disease: a Phase 2, multicenter, open-label randomized cross-over trialDenmark DenmarkFinland FinlandThe Netherlands The NetherlandsNot Yet Recruiting
Assessment of Pulmonary Fibroblast Activity Using [68Ga]FAPI-46 PET/CT in Patients with Post-Acute Sequelae of COVID-19The Netherlands The NetherlandsRecruiting
Assessment of Somatostatin Receptor 2 Expression in Nasopharyngeal Carcinoma Using [68Ga]Ga-DOTA-TOC PET/CT Imaging: A Pilot StudyThe Netherlands The NetherlandsRecruiting
Autologous Transplantation of Adult Salivary Gland Stem Cells for Submandibular Gland Function Restoration Post-Radiotherapy in Head and Neck Cancer PatientsThe Netherlands The NetherlandsRecruiting
Comparative Efficacy of Oral Esketamine Versus Electroconvulsive Therapy in Non-Psychotic Treatment-Resistant Unipolar DepressionThe Netherlands The NetherlandsNot Yet Recruiting
Comparison of BI 690517 and Spironolactone on Renal Hemodynamics and Protein Profiles in Patients with Heart Failure or Cardiovascular Disease and Chronic Kidney DiseaseThe Netherlands The NetherlandsRecruiting
Diagnostic Accuracy of 68Ga-FAPI-46 PET/CT in Patients with Suspected Giant Cell Arteritis–Polymyalgia Rheumatica Spectrum DiseaseThe Netherlands The NetherlandsNot Yet Recruiting
Dual wavelength fluorescence imaging using fluorescently labelled adalimumab and risankizumab for visualizing drug targeting in Inflammatory Bowel Diseases (VOYAGER)The Netherlands The NetherlandsRecruiting
Effect of Survodutide on Albuminuria in Patients with Chronic Kidney DiseaseGermany GermanySpain SpainThe Netherlands The NetherlandsNot Yet Recruiting
1–10 of 76
1 / 8

Data & Insights

science
Molecule Portfolio
Compounds under investigation
10
Exclusive Molecules
out of 91 total (11% not shared with other sponsors)

This sponsor works with 91 molecules, of which 10 are not being studied by other sponsors.

hub
Site Partnerships
Collaboration with research centres
28%
Return partnership rate
40 of 141 sites collaborated multiple times

This sponsor has worked with 141 sites across their trial portfolio.

Therapeutic Focus

  • 1.
    Neoplasms27 trials
    853 other sponsors
  • 2.
    Immune System Diseases11 trials
    322 other sponsors
  • 3.
    Cardiovascular Diseases10 trials
    359 other sponsors
  • 4.
    Digestive System Diseases9 trials
    280 other sponsors
  • 5.
    Diagnosis6 trials
    83 other sponsors
  • 6.
    Nutritional and Metabolic Diseases6 trials
    211 other sponsors
  • 7.
    Respiratory Tract Diseases6 trials
    277 other sponsors
  • 8.
    Mental Disorders4 trials
    150 other sponsors
  • 9.
    Nervous System Diseases4 trials
    449 other sponsors
  • 10.
    Female Urogenital Diseases and Pregnancy Complications3 trials
    142 other sponsors
  • 11.
    Hemic and Lymphatic Diseases3 trials
    249 other sponsors
  • 12.
    Musculoskeletal Diseases3 trials
    238 other sponsors
  • 13.
    Therapeutics3 trials
    87 other sponsors
  • 14.
    Congenital, Hereditary, and Neonatal Diseases and Abnormalities2 trials
    165 other sponsors
  • 15.
    Hormonal diseases2 trials
    89 other sponsors
  • 16.
    Pathological Conditions, Signs and Symptoms2 trials
    91 other sponsors
  • 17.
    Bacterial Infections and Mycoses1 trial
    180 other sponsors
  • 18.
    Behavior and Behavior Mechanisms1 trial
    38 other sponsors
  • 19.
    Biological Phenomena1 trial
    8 other sponsors
  • 20.
    Immune system processes1 trial
    65 other sponsors
  • 21.
    Male Urogenital Diseases1 trial
    111 other sponsors
  • 22.
    Not possible to specify1 trial
    220 other sponsors
  • 23.
    Psychological Phenomena1 trial
    20 other sponsors
  • 24.
    Skin and Connective Tissue Diseases1 trial
    247 other sponsors
  • 25.
    Surgical Procedures, Operative1 trial
    58 other sponsors
  • 26.
    Virus Diseases1 trial
    182 other sponsors

Partnered Research Centres

141 centres
location_city
assignment61
Academisch Ziekenhuis Leiden
Address
Albinusdreef 2, 2333 ZA Leiden
Learn morearrow_forward
location_city
assignment2
Admiraal de Ruijter ziekenhuis
Address
's-Gravenpolderseweg 114, 4462RA Goes
Learn morearrow_forward
location_city
assignment126
Albert Schweitzer Ziekenhuis
Address
Albert Schweitzerplaats 25, 3318 AT Dordrecht
Learn morearrow_forward
location_city
assignment283
Algemeen Ziekenhuis Delta
Address
Deltalaan 1, 8800 Roeselare
Learn morearrow_forward
location_city
assignment163
Algemeen Ziekenhuis Groeninge
Address
President Kennedylaan 4, 8500 Kortrijk
Learn morearrow_forward
location_city
assignment38
Alrijne Zorggroep Stichting
Address
Simon Smitweg 1, 2353 GA Leiderdorp
Learn morearrow_forward
Page 1 of 24

Want to get in touch with this sponsor?

Send a question and we'll pass it on to Universitair Medisch Centrum Groningen.

Need a custom report on this sponsor?

Competitive positioning, market entry, partnership opportunities — tell us the question.

Is something out of date?

Tell us what needs correcting and we'll update this profile.